Cargando…
Pharmacokinetics of Sugammadex Dosed by Actual and Ideal Body Weight in Patients With Morbid Obesity Undergoing Surgery
This analysis of a published study (NCT03346070) evaluated the pharmacokinetics (PKs) of sugammadex dosed by actual body weight (ABW) or ideal body weight (IBW) for reversal of moderate or deep neuromuscular block (M‐NMB or D‐NMB) in adults with morbid obesity. Adults with body mass index ≥ 40 kg/m(...
Autores principales: | Mostoller, Kate, Wrishko, Rebecca, Maganti, Lata, Herring, W. Joseph, van Zutphen‐van Geffen, Mariëlle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7993252/ https://www.ncbi.nlm.nih.gov/pubmed/33278332 http://dx.doi.org/10.1111/cts.12941 |
Ejemplares similares
-
Actual versus ideal body weight dosing of sugammadex in morbidly obese patients offers faster reversal of rocuronium- or vecuronium-induced deep or moderate neuromuscular block: a randomized clinical trial
por: Horrow, Jay C., et al.
Publicado: (2021) -
Sugammadex and Ideal Body Weight in Bariatric Surgery
por: Sanfilippo, Maria, et al.
Publicado: (2013) -
Sugammadex and Ideal Body Weight in Bariatric Surgery: The Debate Continues
por: Carron, Michele
Publicado: (2014) -
Pulse-contour derived cardiac output measurements in morbid obesity: influence of actual, ideal and adjusted bodyweight
por: Boly, Chantal A., et al.
Publicado: (2017) -
Sugammadex by ideal body weight versus 20% and 40% corrected weight in bariatric surgery – double-blind randomized clinical trial
por: Duarte, Nádia Maria da Conceição, et al.
Publicado: (2017)